Aratana Therapeutics

Parent Company

Aratana Therapeutics

US Headquarters Location:

Leawood, KS

Website Address:

Number of Employees:



Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, is a fast-growing company headquartered in Leawood, Kansas with offices in San Diego and Leuven, Belgium. Aratana intends to become the leader in pet therapeutics by developing, manufacturing and marketing products that address unmet or underserved medical needs of pets.
Aratana intends to be a fully-integrated commercial company in the United States with up to six therapeutic product marketing authorizations anticipated in 2016. Aratana has developed and received FDA approval for an EP4 prostaglandin receptor antagonist for the pain and inflammation associated with osteoarthritis in dogs as well as a ghrelin agonist for the stimulation of appetite. Aratana has two monoclonal antibodies licensed from USDA to aid in the treatment of T-cell and B-cell lymphoma in dogs. The pipeline includes therapeutic candidates for post-operative pain, osteosarcoma, allergy, viral diseases and other unmet needs.

Aratana is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.


Current Job Postings

Job ID Job Title Location